| Nicholas Ken Muraoka, DO | |
|
226 N Kuakini St, Honolulu, HI 96817-2488 | |
| (808) 531-3511 | |
| (808) 544-3335 |
| Full Name | Nicholas Ken Muraoka |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 14 Years |
| Location | 226 N Kuakini St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295034866 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Clarence Tc Ching Villas At St Francis | Honolulu, HI | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehab Associates Of The Pacific Llc | 6608190822 | 8 |
| Rehabilitation Hospital Of The Pacific | 9436068442 | 7 |
News Archive
A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science.
For every 1,000 children born in the U.S. today, two to three are at risk for developing cerebral palsy because of injuries to the brain that may have occurred prior to or during birth. There is currently no cure for cerebral palsy, but Newborn Possibilities is a first-of-its-kind program recently launched in Tucson, which may offer new options for newborns at-risk for neurological injury.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 6 days ago
| Entity Name | Rehab Associates Of The Pacific Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114322880 PECOS PAC ID: 6608190822 Enrollment ID: O20150117000100 |
News Archive
A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science.
For every 1,000 children born in the U.S. today, two to three are at risk for developing cerebral palsy because of injuries to the brain that may have occurred prior to or during birth. There is currently no cure for cerebral palsy, but Newborn Possibilities is a first-of-its-kind program recently launched in Tucson, which may offer new options for newborns at-risk for neurological injury.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 6 days ago
| Entity Name | Rehabilitation Hospital Of The Pacific |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1730580424 PECOS PAC ID: 9436068442 Enrollment ID: O20150311001024 |
News Archive
A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science.
For every 1,000 children born in the U.S. today, two to three are at risk for developing cerebral palsy because of injuries to the brain that may have occurred prior to or during birth. There is currently no cure for cerebral palsy, but Newborn Possibilities is a first-of-its-kind program recently launched in Tucson, which may offer new options for newborns at-risk for neurological injury.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 6 days ago
| Entity Name | Nicholas Muraoka Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104207406 PECOS PAC ID: 4981917960 Enrollment ID: O20150720002731 |
News Archive
A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science.
For every 1,000 children born in the U.S. today, two to three are at risk for developing cerebral palsy because of injuries to the brain that may have occurred prior to or during birth. There is currently no cure for cerebral palsy, but Newborn Possibilities is a first-of-its-kind program recently launched in Tucson, which may offer new options for newborns at-risk for neurological injury.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 6 days ago
| Entity Name | Mi-health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154064855 PECOS PAC ID: 0143605030 Enrollment ID: O20220913002100 |
News Archive
A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science.
For every 1,000 children born in the U.S. today, two to three are at risk for developing cerebral palsy because of injuries to the brain that may have occurred prior to or during birth. There is currently no cure for cerebral palsy, but Newborn Possibilities is a first-of-its-kind program recently launched in Tucson, which may offer new options for newborns at-risk for neurological injury.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Ken Muraoka, DO 226 N Kuakini St, Honolulu, HI 96817-2488 Ph: (808) 531-3511 | Nicholas Ken Muraoka, DO 226 N Kuakini St, Honolulu, HI 96817-2488 Ph: (808) 531-3511 |
News Archive
A "nuisance" is probably one of the nicest things people call mosquitoes. Mosquitoes have been called the deadliest animal on the planet, because of the diseases they spread.
Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).
These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science.
For every 1,000 children born in the U.S. today, two to three are at risk for developing cerebral palsy because of injuries to the brain that may have occurred prior to or during birth. There is currently no cure for cerebral palsy, but Newborn Possibilities is a first-of-its-kind program recently launched in Tucson, which may offer new options for newborns at-risk for neurological injury.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 6 days ago
Dr. Damien Kekaneinoa Tavares Iii, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2226 Liliha Street, Suite 407, Honolulu, HI 96817 Phone: 808-445-9172 Fax: 808-445-9182 |